In the studies presented here, APE1 was knocked down using siRNA in low‐passage patient‐derived pancreatic ductal adenocarcinoma (PDAC) cells, and the resulting cells, together with control cells treated with scrambled siRNA, were analyzed using scRNA‐seq. Here, APEX1 is linked to pancreatic ductal adenocarcinoma.